Recommended Resources
- Body Mass Index Calculator
- Broken Link Checker
- Browser Shots
- Cancer Specialist
- HGH
- HGH Injections
- Hormone Decline Graphs / Calculator
- Hormone Therapy
- Human Growth Hormone
- Medical Dictionary Search
- Medical Drugs Search
- Medical Symptoms Search
- Quality of Life Assessment
- Ron Paul 2012
- Ron Paul TV
- Testosterone
- Testosterone Replacement Therapy
- Testosterone Therapy
- Weight Loss
Categories
- Anatomy
- Biochemistry
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Cardiology
- Cell Medicine
- Cell Therapy
- Chemistry
- DNA
- Embryology
- Future Medicine
- Gene Medicine
- Gene Therapy
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Human Genetics
- IVF Treatment
- Longevity Medicine
- Medical News
- Medical School
- Medical Technology
- Medicine
- Molecular Genetics
- Molecular Medicine
- Muscular Dystrophy Stem Cells
- Nano Medicine
- Nanotechnology
- Pet Stem Cell Therapy
- Stem Cell Therapy
Archives
Category Archives: Genetics
Myriad Genetics Announces Presentation of Lung Cancer Study at American Society for Clinical Oncology Annual Meeting
SALT LAKE CITY, May 16, 2012 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN – News) announced today the presentation of a study at the American Society of Clinical Oncology(R) (ASCO) Annual Meeting, including the complete results from a study titled, “Use of a proliferation-based mRNA signature to predict outcome in early-stage non-small cell lung adenocarcinoma.” The abstract of the presentation (#7023) is available on the ASCO Meeting website, www.asco.org. Researchers at MD Anderson Cancer Center and Myriad Genetics generated a cell cycle progression (CCP) score for 256 patients with stage I and II lung adenocarcinoma by analyzing the level of expression in 46 cell-cycle progression and housekeeping genes. Continue reading
Posted in Genetics
Tagged ability, development, lake, presentation, press, press-release, technology, united-states
Comments Off
Seattle Genetics to Present ADCETRIS® and ASG-5ME Data at ASCO Annual Meeting
BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (NASDAQ:SGEN – News) today announced that data from two of its antibody-drug conjugate (ADC) programs, ADCETRIS (brentuximab vedotin) and ASG-5ME, will be presented at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting being held June 1-5, 2012 in Chicago, IL. Continue reading
Posted in Genetics
Tagged a-from-two, a-linker-system, accessed-on-the, annual-meeting, asco, bloodstream, chicago, full-abstracts, linker-system, refractory-non-, the-bloodstream, today-announced, tumor-cells, website-at-www
Comments Off
Cancer Genetics IPO Faces Facebook
Cancer Genetics is pursuing a strategy that differs from Facebook’s IPO plan, expert says. Continue reading
Posted in Genetics
Tagged a-quick-profit, below-the-peak, chairman, chance, florida, long, nasdaq-, north-jersey, officer-panna, university
Comments Off
Applied Genetics Signs Agreement With The National University Of Mexico (UNAM)
WESTMINSTER, Colo., May 16, 2012 /PRNewswire/ — GeneThera, Inc. (GTHR.PK) announced today that Applied Genetics, GeneThera’s majority owned subsidiary, signed a research and test validation agreement with Universidad National Autonoma de Mexico (UNAM). Continue reading
Response Genetics, Inc. Announces First Quarter Financial Results
Response Genetics Inc. , , a company focused on the development and sale of molecular diagnostic tests for cancer, today announced its consolidated finaSource:http://news.search.yahoo.com/news/rss?p=genetics&ei=UTF-8&fl=0&x=wrt
Posted in Genetics, Human Genetics
Comments Off
Seattle Genetics Announces Data from Investigator Trial of ADCETRIS™ in Relapsed Cutaneous T-Cell Lymphoma
Seattle Genetics, Inc. today announced that interim results from an investigator-sponsored phase II clinical trial of ADCETRIS in patients with relapsed cutaneous T-cell lymphoma were presented at the Society for Investigative Dermatology annual meeting being held May 9-12, 2012 in … Continue reading
Posted in Genetics, Human Genetics
Comments Off
Seattle Genetics to Present at Bank of America Merrill Lynch Health Care Conference
BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (NASDAQ:SGEN – News) announced today that management will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Tuesday, May 15, 2012 at 1:00 p.m. Continue reading
Posted in Genetics
Tagged agreements-with, america, america-merrill, announced-today, daiichi-sankyo, development, genetics, genmab-more, investors, pacific-time, seattle, seattle-genetics, takeda-oncology, the-development, website-at-www
Comments Off
NewLink Genetics Corporation Reports First Quarter 2012 Financial Results
AMES, Iowa, May 10, 2012 (GLOBE NEWSWIRE) — NewLink Genetics Corporation (Nasdaq:NLNK – News), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today reported consolidated financial results for the first quarter of 2012, and provided an update on the progress of its clinical development programs. “During the first quarter of 2012 we continued to advance our pivotal trial in pancreatic cancer and are also moving forward on a number of other HyperAcute immunotherapy development programs including those to treat melanoma and lung and kidney cancers,” commented Dr. Charles Link, Chairman and Chief Executive Officer of NewLink. Continue reading
Posted in Genetics
Tagged a-and-lung, accomplishments, based-on-its, chairman, developing-and, first, following, genetics, presenting-new, progress, the-following, these-programs, update-on-the
Comments Off
Interleukin Genetics Reports First Quarter 2012 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)– Interleukin Genetics,Inc. (OTCQB: ILIU.PK – News) today announced financial and operational results for the first quarter ended March 31, 2012. Total revenue for the three months ended March 31, 2012 was $678,000, compared to $719,000 for the same period in the prior year Continue reading
Posted in Genetics
Tagged a-net-loss, first, management, prior, quarter, same, three, university, utility
Comments Off
Stuart Newman: The New Business of Genetic Determinism- Tarrytown 2010 – Video
07-05-2012 17:41 Stuart Newman, Professor of Cell Biology and Anatomy at New York Medical College, discusses challenge to human identity and the blurring of the distinction of organism and artifact arising from the intersection of technology and the corporate culture at the 2010 Tarrytown Meeting. The Tarrytown Meetings bring together people working to ensure that human biotechnologies and related emerging technologies support rather than undermine social justice, equality, human rights, ecological integrity and the common good. Continue reading
Posted in Genetics
Tagged a-close-family, california, corporate, google, medical, medical-college, most, people-, stuart-newman, tarrytown, the-distinction
Comments Off
Jonathan Kahn: Setting the Stage for Understanding Genetic Technologies- Tarrytown 2010 – Video
07-05-2012 15:43 Jonathan Kahn, Professor at Hamline University School of Law, frames how the relationship between genetics and society should be understood in an opening plenary at the 2010 Tarrytown Meeting. Continue reading
Posted in Genetics
Tagged check-out-the, common, common-good-, find-out-more, human-rights, opening-plenary, plenary-at-the, professor, school, support-rather, tarrytown
Comments Off
Genetics Researchers Net Albany Prize [Medical News & Perspectives]
Two scientists at Rockefeller University who have helped elucidate the pathways involved in the regulation and expression of genes have been awarded the 2012 Albany Medical Center Prize in Medicine and Biomedical Research. The 2012 Albany Medical Center Prize in Medicine and Biomedical Research is being shared by James E. Continue reading
Posted in Genetics
Tagged and-expression, biomedical, contributions, laboratory, medicine, morris-marty, rockefeller, the-laboratory, understanding, united, university
Comments Off
Millennium and Seattle Genetics Initiate Global Phase 3 Trial of ADCETRIS™ in Patients with CD30-Expressing Relapsed …
CAMBRIDGE, Mass. Continue reading
Posted in Genetics
Tagged a-from-patients, a-linker-system, australia-, ctcl, european, initiation, millennium, patients-with, united-states, ventana-medical
Comments Off
Seattle Genetics pares 1Q loss on Adcetris sales
Seattle Genetics Inc. said Tuesday it took a smaller loss in the first quarter after launching its cancer drug Adcetris. Continue reading
Posted in Genetics
Tagged extended-trading-, forecasts-and, genetics, its-shares, launching-its, quarter, quarter-after, seattle-genetics, street, the-first, the-quarter, tuesday
Comments Off
Seattle Genetics Reports First Quarter 2012 Financial Results
BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (Nasdaq:SGEN – News) today reported financial results for the first quarter ended March 31, 2012. The company also highlighted the ADCETRIS (brentuximab vedotin) product launch, ongoing and planned clinical development activities and upcoming milestones Continue reading
Posted in Genetics
Tagged a-from-these, acceptance, and-utilization, chief-executive, collaborators, financial, first, public-health, upcoming
Comments Off
Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2012 Financial Results on May 8, 2012
Seattle Genetics, Inc. announced today that it will report its first quarter 2012 financial results on Tuesday, May 8, 2012, after the close of financial markets. Following the announcement, company management will host a conference call and webcast discussion of … Continue reading
Posted in Genetics, Human Genetics
Comments Off
Research and Markets: Genetics, 6th Edition International Student Version Continues To Educate Today's Students for …
Dublin – Research and Markets has announced the addition of John Wiley and Sons Ltd's new book "Genetics, 6thSource:http://news.search.yahoo.com/news/rss?p=genetics&ei=UTF-8&fl=0&x=wrt
Posted in Genetics, Human Genetics
Comments Off
Genetics play role in taste perception of meat, say researchers
Genetic differences in odorant receptors could account for as much as 40% variation in taste intensity of foods, according to new research.Source:http://news.search.yahoo.com/news/rss?p=genetics&ei=UTF-8&fl=0&x=wrt
Posted in Genetics, Human Genetics
Comments Off
NewLink Genetics Receives Notice of Allowance From USPTO for New Patent Broadly Covering Its D-1MT IDO Pathway Inhibitor
AMES, Iowa — NewLink Genetics Corporation today announced that the United States Patent & Trademark Office (USPTO) has allowed broad claims to oral pharmaceutical compositions comprising 1-methyl-D-tryptophan …Source:http://news.search.yahoo.com/news/rss?p=genetics&ei=UTF-8&fl=0&x=wrt
Posted in Genetics, Human Genetics
Comments Off